Mounting Evidence Of Increased Mortality From Drug Used By Anemic Cancer Patients

Millions of cancer patients take drugs to boost their red blood cells and health when they become anemic after chemotherapy. But a new study by Northwestern University’s Feinberg School of Medicine shows these drugs, called erythropoiesis-stimulating agents (ESAs), actually raise patients’ risk of death, possibly by stimulating the growth of cancer cells.

More: continued here

Filed under: Blood on February 27th, 2008